On September 12, UnitedHealth fell 3.01% in regular trading, trading at $376.35/share, with turnover of $1.565 billion. The stock has been under sustained selling pressure since the company disclosed the sale of a partial equity stake in its Florida-based Optum Health operations to private equity giant TPG.
The transaction involves UnitedHealth's WellMed clinic network, which primarily serves older adults. Optum Health suffered a sharp profit decline last year as rising medical costs and changes in federal payment mechanisms pushed the division's margins into negative territory, prompting ongoing restructuring efforts. While management stated the TPG partnership would allow the business to invest and expand faster — with approximately 15 new clinics opening annually in Florida — investors have interpreted the asset sale negatively.
Market concerns center on the pace of Optum Health's profitability recovery and the broader group transformation outlook. UnitedHealth has undergone significant leadership changes, including replacing its CEO and several senior executives following the earnings setback. Despite a strong Q2 report in July that beat estimates and prompted multiple analyst target price upgrades — with a mean target around $478 — the stock has retreated notably since the TPG deal was announced on September 9.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments